ReviewJournal of pain research2026
Therapeutic Soreness in Manual Therapy for Chronic Neck Pain: A Triphasic Model of Descending Pain Modulation.
Review in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic neck pain (CNP) is a complex condition shaped by both peripheral tissue dysfunction and central nociplastic changes, including dysregulated endogenous pain modulation. Manual therapy (MT) is a guideline-endorsed intervention, but its mechanism of action remains debated. Moving beyond purely biomechanical accounts, we propose, as a working hypothesis rather than an established finding, that MT's clinical effects may be substantially mediated by neurophysiological modulation, particularly recruitment of descending inhibitory pathways. Mechanism: We synthesize contemporary evidence to propose that the "therapeutic soreness" some patients report during MT may indicate an afferent stimulus intensity sufficient to engage deep somatic Aδ and C-fiber input to the descending pain-modulatory system, centered on the Periaqueductal Gray (PAG)-Rostral Ventromedial Medulla (RVM) loop. We also review animal pharmacology implicating Locus Coeruleus (LC) noradrenergic and endocannabinoid signaling in shifting RVM output toward antinociceptive OFF-cell dominance; whether this specific chain operates during manual therapy in humans has not been directly tested. Perspective: We propose a conceptual, non-linear triphasic (Zone 1-2-3) dose-response framework as a hypothesis-generating tool, not a validated protocol. Subthreshold loading (Zone 1) is proposed to produce local tissue effects without engaging robust central modulation. An intermediate intensity (Zone 2), clinically associated with tolerable "therapeutic soreness", is hypothesized to engage descending inhibition through mechanisms that resemble, but are not equivalent to, Conditioned Pain Modulation (CPM-like effects). Loading beyond this window (Zone 3) is proposed to shift the balance toward central facilitation, potentially reinforcing rather than resolving the pain-tension cycle. Conclusion: This framework offers a testable, neurobiologically motivated rationale for individualizing MT dosing, particularly in sensitized phenotypes where the therapeutic window may be narrowed. It requires empirical validation, including objective sensorimotor and neuroimmune biomarkers, before it can inform clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.